Pharma Journalist 8887 posts 0 comments

Zydus Lifesciences has announced a major strategic partnership with Germany-based Formycon AG to develop and commercialize FYB206, a biosimilar version of the blockbuster immunotherapy…
Read More...

Ajax Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to AJ1-11095, the company’s next-generation JAK inhibitor being…
Read More...

Eli Lilly and Company has announced plans to invest over $6 billion in a new manufacturing facility in Huntsville, Alabama, aimed at producing next-generation synthetic medicine active…
Read More...

Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved its epinephrine injection USP, 1 mg/mL, in both single-dose (1 mL) and multi-dose (30 mL)…
Read More...

Pfizer has entered into a global collaboration and licensing agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, to advance the development of YP05002, an…
Read More...

Roche announced that the European Commission has granted approval for Gazyva®/Gazyvaro® (obinutuzumab) combined with mycophenolate mofetil (MMF) to treat adults with active Class III or…
Read More...

Inductive Bio, an AI-driven drug discovery company known for developing virtual chemistry laboratories, has been awarded up to $21 million to lead a groundbreaking project aimed at…
Read More...

Viatris Inc. has entered into definitive agreements with Biocon Limited for the sale of its full equity stake in Biocon Biologics Limited, marking a major strategic move as the company…
Read More...

January 27-29, 2026 | Boston, MA – With the exciting news of Novartis acquiring Avidity Biosciences, SanegeneBio and Eli Lilly's partnership worth $1.2B to develop RNAi therapeutics for…
Read More...

Ionis Pharmaceuticals has received a significant boost in its neurology pipeline with the U.S. Food and Drug Administration granting Breakthrough Therapy designation to zilganersen, the…
Read More...